Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial. (2018)

First Author: Bahig H
Attributed to:  Development of MRI-guided radiation therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ctro.2018.08.003

PubMed Identifier: 30386824

Publication URI: http://europepmc.org/abstract/MED/30386824

Type: Journal Article/Review

Volume: 13

Parent Publication: Clinical and translational radiation oncology

ISSN: 2405-6308